Send the Exact Correction.

Editorial correspondence

The desk accepts notes about citations, compound identity, study design, regulatory framing, and evidence level. The most useful message names the page, quotes the passage at issue, and supplies the primary source that supports a correction. A journal citation, stable database record, or formal regulatory document is enough to begin a check.

The desk is especially interested in identity errors. TB-500 fragment evidence must remain separate from full-length thymosin beta-4 evidence. Animal outcomes must remain labeled by species. Combination-formulation results must not be assigned to a single ingredient. Safety observations must not be retold as efficacy.

Editorial mailbox: editors@acsendpeptides.com

Scope of reply

Acsend Peptides does not answer purchasing, sourcing, personal dosing, diagnosis, treatment, or protocol questions. It does not evaluate individual symptoms. It does not verify research-grade products. Those requests sit outside the editorial scope.

Source-backed corrections are reviewed against the signed corpus and the cited publication. A note may reveal a wording problem without changing the evidence level. It may also identify a material issue: wrong molecule, wrong species, wrong endpoint, or unsupported numerical precision. Those corrections receive priority.

General feedback is welcome. Promotional submissions are not part of the record. Supplier testimonials do not replace controlled evidence. Unpublished anecdotes may describe a signal, but they cannot establish frequency, causation, efficacy, or safety.

Before writing

The comparison page states the site's evidence framework. The references page lists the complete current source set. Reading both often resolves whether a disagreement concerns the underlying study or the strength assigned to it.

Keep the note narrow. State the proposed change. State why the current language fails. Link the best available primary source. The desk will handle the rest.